Michael Zile to Sarcoplasmic Reticulum
This is a "connection" page, showing publications Michael Zile has written about Sarcoplasmic Reticulum.
Connection Strength
0.058
-
A phase II, double-blind, randomized, placebo-controlled, dose comparative study of the efficacy, tolerability, and safety of MCC-135 in subjects with chronic heart failure, NYHA class II/III (MCC-135-GO1 study): rationale and design. J Card Fail. 2004 Jun; 10(3):193-9.
Score: 0.058